GBM64 GBM Model

GBM64, a Patient-Derived Xenograft (PDX) model, is designed for brain cancer research. Use this model to explore the disease’s complexity and develop novel therapeutic strategies. PDX models like GBM64 bridge the gap between laboratory research and clinical trials. Researchers can leverage GBM64 to test potential drug candidates in an environment that closely resembles the human disease, increasing the chances of success in subsequent phases of drug development. GBM64 contributes to accelerated drug discovery and improved outcomes for brain cancer patients.

Model Details

Cancer Location: Intracranial
Cancer Type: Brain Cancer
Model Name: GBM64
Mouse Strain: Nu/Nu
RNAseq: Yes
Methylation: Yes
PDX Treatment: Yes
Patient Treatment History: Yes

GBM64 Survival

GBM64 GBM Model

Survival of orthotopic intracranial implanted GBM64 in Nu/Nu mice (n=5)

Request Additional GBM Model Data


Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our expert staff today to get started.